Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

BLCO


Fundamental

Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -1.03
Insider Own: 89.68%
Shs Outstand: 353.36M
Perf Week: -1.31%
Market Cap: 4.25B
Forward P/E: 15.71
EPS next Y: 0.77
Insider Trans: 0.01%
Shs Float: 36.48M
Perf Month: 7.02%
Enterprise Value: 8.94B
PEG: -
EPS next Q: 0.07
Inst Own: 9.85%
Short Float: 6.97%
Perf Quarter: -24.32%
Income: -362.00M
P/S: 0.88
EPS this Y: -28.63%
Inst Trans: 7.92%
Short Ratio: 2.84
Perf Half Y: -33.99%
Sales: 4.83B
P/B: 0.67
EPS next Y Percentage: 70.47%
ROA: -2.71%
Short Interest: 2.54M
Perf YTD: -33.33%
Book/sh: 18.00
P/C: 19.79
EPS next 5Y: 17.07%
ROE: -5.56%
52W High: 21.69 -44.49%
Perf Year: -20.21%
Cash/sh: 0.61
P/FCF: -
EPS past 3/5Y: - -
ROIC: -3.25%
52W Low: 10.45 15.22%
Perf 3Y: -16.91%
Dividend Est.: -
EV/EBITDA: 15.21
Sales past 3/5Y: 8.36% 4.87%
Gross Margin: 54.21%
Volatility W: 1.15%
Volatility M: 2.34%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 1.85
EPS Y/Y TTM: -6.98%
Oper. Margin: 3.23%
ATR (14): 0.43
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 0.96
Sales Y/Y TTM: 11.94%
Profit Margin: -7.50%
RSI (14): 51.94
Recom: 2.44
Dividend Gr. 3/5Y: - -
Current Ratio: 1.56
EPS Q/Q: -26.32%
SMA20: 1.53%
Beta: 0.57
Target Price: 14.04
Payout: -
Debt/Eq: 0.76
Sales Q/Q: 3.46%
SMA50: 1.00%
Rel Volume: 0.57
Prev Close: 12.00
Employees: 13500
LT Debt/Eq: 0.75
Earnings: Apr 30 BMO
SMA200: -25.97%
Avg Volume: 894.49K
Price: 12.04
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: -433.33% -1.16%
Trades:
Volume: 508,777
Change: 0.33%

Technical:


Latest News:

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO

Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.

Full article
2024-04-24T20:31:52Z